One such approach is utilizing oncolytic adenovirus gene therapy to deliver TP53 into cancer, such as Gendicine [60] and Oncorine [61], which has been approved for treating cancer by the China Food and Drugs Administration (CFDA). This evidence concerns the gene TP53 and cancer.